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Summary Although the research base on mental health in intellectual disabilities is
advancing, there are long-standing barriers that hinder successful completion of
funded studies. A variety of stakeholders hold the key to mitigating the challenges
and arriving at sustainable solutions that involve researchers, experts by experience,
clinicians and many others in the research pathway. Lessons learned during the
COVID-19 pandemic can also contribute to improvements in the conduct of research
in the medium to long term. People with an intellectual disability and mental health
conditions deserve high standards of evidence-based care.
Keywords Consent and capacity; intellectual disability; service users; psychosocial
interventions; randomised controlled trial.
Research evidence is essential in supporting professional
decision-making for the benefit of patients across health
and social care. The benefits of participation in research
include better outcomes and more efficient use of resources,
with harmful or unhelpful treatments being phased out.
A major driver for funded applied health and social care
research is the increase in research capacity and the comple-
tion of high-quality studies on priority topics that have been
identified by stakeholders, including scientists and the
public. In the UK, the substantial annual investment of
more than £1 billion by the National Institute for Health
Research (NIHR) supports both projects spanning the
range of methodologies and the infrastructure to underpin
the endeavour.
Recognising the challenges of investing and supporting
research in health and social care organisations, NHS
England and the NIHR published a joint report1 that
included 12 actions that would help to relieve the bottleneck
many chief investigators encounter at the setting-up and
recruitment phases. Two major stumbling blocks at the
time were setting excess treatment costs with regard to
treatment delivery, and research governance; the latter
ranges from ethical approval to assessment of local capacity
and capability in agreeing recruitment targets.
Although progress has been made, these issues, which
are common in research activity across many different
health and social care domains, have not completely resolved
3 years on. In this editorial we address a variety of both bar-
riers to research and facilitators of research, with a specific
focus on research in intellectual disability services. We
argue that such problems may be relevant in research in
other hard-to-reach populations who may or may not have
cognitive impairment.
Since the launch of the NIHR in the UK in 2006, there
has been an increase in the number of funded studies inves-
tigating a variety of research questions in intellectual dis-
abilities, including developing, adapting and testing
interventions in randomised controlled trials (RCTs). The
majority of these are trials of psychosocial interventions.
However, the portfolio of studies remains small compared
with other fields of medicine, estimated at 1.4% of all
NIHR-funded studies.2
People with intellectual disabilities (global developmen-
tal delay evident in childhood that affects adaptive function-
ing) account for approximately 2% of the population in the
UK and are more likely to suffer health-related multimor-
bidity, higher and earlier mortality and face significant
inequalities.3 Many lack capacity and therefore decisions
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about their participation in research depend on families’ and
paid carers’ understanding and attitudes towards research
projects and research processes. This is because they may
be called on to act as consultees to enable participation of
those most vulnerable. It is therefore essential that people
lacking capacity should also be able to take part in and bene-
fit from research specific to people with intellectual disabil-
ities, with appropriate safeguards as mandated in the Mental
Capacity Act 2005 or equivalent permissions internationally.
Barriers
Despite the amount of research conducted over time, many
challenges that have been reported previously still remain
and have an impact on the completion of studies. Lennox
et al4 described identification of substantial numbers of par-
ticipants, frequent need for substituted decision-making,
occasional limited literacy of both person and carer, and
organisational gate-keeping practices as significant barriers
to recruitment in an RCT of health checks in Australia.
More recently, a systematic review of 53 papers reporting
RCTs in people with intellectual disabilities published
between 2000 and 20175 identified similar barriers in
recruiting to target, participant treatment preferences,
engaging with stakeholders, obtaining consent and staff
turn-over. Optimistically the authors concluded, ‘conducting
RCTs with people with cognitive disabilities can be challen-
ging, however, with reasonable adjustments, many of these
barriers can be overcome’.
People with intellectual disabilities are excluded from
research that may be relevant to their health vulnerabil-
ities,2 as well as being sceptical about the impact of it on
their lives. This is illustrated by the Research Voices pro-
ject,6 which revealed a number of serious concerns that par-
ents of people with profound and multiple disabilities
harbour about research, such as mistrust of health profes-
sionals seeking participants for studies, the emotional and
time burden of research assessments, frustration with not
knowing the findings or findings not translating to real
improvements in practice.
Research infrastructure brings its own multifaceted
challenges. The role of clinical research practitioners
(CRPs) (who are National Health Service (NHS) based and
able to recruit from services directly) is not fully understood
by intellectual disability services and there is significant
variation among the operations of clinical research networks
across the different UK countries. Therefore, professionals
in the services may be asked to undertake recruitment in
addition to an already busy clinical role. Further, data guar-
antors are frequently local authorities, who are providers of
social care services not directly connected to the NHS in
England. Finally, intellectual disability services that are
located outside NHS structures have fewer opportunities
to be informed of ever-evolving research processes, thus
remaining unable to utilise available resources to assist
them in incorporating and supporting research in their
day-to-day practice.
Clinician factors are also important in maintaining
non-engagement in research activities, including older age,
being male and working in the private sector.7 Oliver-
Africano et al8 identified beliefs about drug efficacy, poten-
tial ethical conflicts in medication trials and multidisciplin-
ary team processes as having adversely affected recruitment
to a clinical trial of antipsychotics in adults with intellectual
disabilities. Delays associated with any of these factors inev-
itably matter in completing studies that depend on time-
sensitive research contracts and are likely to hamper the val-
idity of the research findings if there is underrecruiting.
Finally, clinicians and scientists in general may not
make sufficient effort to include participants from underre-
presented groups in their studies, thus perpetuating the lim-
ited access of people with intellectual disabilities in research.
This is particularly important for diseases where it has been
demonstrated that there is excess morbidity and/or mortal-
ity in this population.9
Facilitators
Prioritisation of research is likely to confer benefits to both
health and care organisations, as shown by views reported in
a review of engagement in research:10
‘The wider review demonstrated [. . .] how collaborative and
action research can encourage some progress along the path-
way from research engagement towards improved health-
care performance. There is also evidence that organisations
in which the research function is fully integrated into the
organisational structure, out-perform other organisations
that pay less formal heed to research and its outputs.’
These lessons, although not specific to intellectual disabil-
ities, are relevant in this context as presenting a justification
for embracing research by the multitude of service config-
urations delivering care to this population.
In other changes to research governance, the new
Health Research Authority has halved the time needed to
obtain regulatory approvals,11 although other milestones
along the research pathway remain areas of concern.
Although the funding for research in intellectual disabil-
ities may be lower than what is essential for investigating the
increased morbidity, mortality and the health inequalities
seen in this population group, there is an emerging cohort
of completed high-quality studies. There are also many com-
mitted researchers, healthcare service professionals and
other staff whose enthusiasm and problem-solving capacity
signal their willingness to engage with the process. These
may further promote interest in research by influencing
national clinical practice and through targeted dissemin-
ation, including to people with intellectual disabilities and
their carers. Clinician familiarity with academic work, peer
support and support from management are also likely to
increase positive attitudes towards research. Research that
is seen as arising out of patient concerns and that could
lead to tangible benefits in interventions and care improve-
ments is also likely to be supported.6
Recently the NIHR Dissemination Centre published a
themed review on intellectual disability research.12 More
than showcasing the funded projects, it highlighted the
meaning of the findings for the care that people with intel-
lectual disabilities and their family carers receive. In add-
ition, the collection of studies included in the review
demonstrate that funded research can be conducted
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successfully in the field of intellectual disabilities but that all
the studies have had significant involvement of people with
intellectual disabilities and their family carers throughout.
These studies are examples of good practice that can be
shared between researchers, people with intellectual disabil-
ities, their carers and charities supporting them.
Solutions
A primary area for mitigation lies in health and social care pro-
fessionals’ and people with intellectual disabilities’ conviction
of the importance of research and its wider contribution to
lives and well-being. A recent course13 devised to train people
with intellectual disabilities in research methods suggests that
learning about conducting research and driving the research
process is feasible. Such courses could increase the number
of suitably trained people with intellectual disabilities who
could be recruited to work as researchers in various projects.
Incentives for encouraging donation of time to research
activities by family and paid carers may improve uptake and
retention, alongside other strategies. Increasingly, experts by
experience are being asked to interpret and comment on
research findings and this is a way of increasing familiarity
with research processes, as well as consumer feedback.
The well-intended efforts of paid carers to protect vul-
nerable adults if they lack capacity, including the personal
data protection regulations, often stifle participant recruit-
ment. In England and Wales, this could be addressed by a
revision of the Mental Capacity Act 2005. Heywood et al14
outlined how the Act is predominantly focuses on treatment
and decision-making within a ‘best interests’ framework,
rather than on research where decisions are not made
using that framework. The sections of the Act governing
research do not effectively balance protection and empower-
ment, and researchers may be reluctant to include partici-
pants who lack capacity in research projects.
The research community may also need to take some
responsibility in providing solutions to the present chal-
lenges. Being clear about what the findings mean to the
wider group of people with intellectual disabilities, proactive
dissemination strategies and other activities in engaging the
public with research are paramount in moving forward.
Research aims to shape service delivery and to translate
advances in science into measurable benefits for the popula-
tion at large. It is questionable whether consumers consider
research findings relevant to their health and whether those
who commission services apply research findings to enhance
clinical effectiveness and value for money.
An example of fostering closer links between clinicians,
academics and people with lived experience of intellectual
disability is the newly formed RADiANT consortium, a plat-
form that works to increase health and social care staff’s
awareness of research and develop research skills and cap-
acity. The consortium is focused on mental health and behav-
ioural problems in intellectual disabilities, autism and other
neurodevelopmental conditions (see radiant.nhs.uk for more
information). So far it has produced guidance on how to
manage the COVID-19 pandemic in different mental health
settings and has delivered several educational activities. Its
wider impact remains to be established.
Professional bodies across all professions must also pro-
mote research-related objectives in training curricula and on
public-facing forums such as websites and newsletters.
Strengthening health and social care links is an area for
further development, especially as social care is identified
by NIHR as a domain for research investment. This means
extension of the research infrastructure to reach the
neglected care sector, which is central to accessing indivi-
duals to take part in research activities as proxy informants.
The coronavirus pandemic has shown that, while con-
tinuing to endorse ethically conducted research, it is pos-
sible to do so at pace.15 It will be important to remember
those lessons as we are coming out of the pandemic and in
the event of future public health emergencies. In particular,
they can inform how to carry out remote research assess-
ments and interviews with participants with intellectual dis-
abilities and ensure that the voice of experts by experience
remains central to research activity. During the pandemic,
people with intellectual disabilities have been disproportion-
ately affected in both their health and social care needs and
require high standards of support in both. We must be able
to reassure them and their families that being partners in
research pays off in achieving those standards.
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